Fibrin D-dimer fragments enhance inflammatory responses in macrophages: Role in advancing atherosclerosis

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 3, 2007, Pages 185-190

  Zhou, Dong ^a   Yang, Peng Yuan ^a   Zhou, Bin ^a   Rui, Yao Cheng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Fibrin D dimer fragments; Foam cell; Inflammatory response; Macrophage

Indexed keywords

CELL ADHESION MOLECULE; D DIMER; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; LIPID; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; VASCULOTROPIN A;

ARTICLE; ATHEROSCLEROSIS; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; FOAM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; LIPID METABOLISM; LIPID TRANSPORT; MACROPHAGE; MACROPHAGE FUNCTION; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION;

ATHEROSCLEROSIS; CELL ADHESION MOLECULES; CELL PROLIFERATION; FIBRIN; GENE EXPRESSION REGULATION; GENE LIBRARY; HUMANS; INDICATORS AND REAGENTS; INFLAMMATION; LIPID METABOLISM; MACROPHAGES; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; U937 CELLS; UP-REGULATION;

EID: 33846452104     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04570.x     Document Type: Article

References (39)

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-43.
2. Glass C, Witztum J. Atherosclerosis. The road ahead. Cell 2001; 104: 503-16.
3. Ross R. Atherosclerosis: An inflammatory disease. N. Engl. J. Med. 1999; 340: 115-26.
4. Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 2002; 8: 1235-42.
5. Spronk HM, van der Voort D, Ten Cate H. Blood coagulation and the risk of atherothrombosis: A complex relationship. Thromb. J. 2004; 2: 12.
6. Folsom AR, Rosamond WD, Shahar E et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The atherosclerosis risk communities (ARIC) study investtigators. Circulation 1999; 100: 736-42.
7. Danesh J, Whincup P, Walker M et al. Fibrin D-dimer and coronary heart disease. Prospective study and meta-analysis. Circulation 2001; 103: 2323-7.
8. Lowe GD, Rumley A, McMahon AD, Ford I, O'Reilly DS, Packard CJ. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 2004; 24: 1529-34.
9. Narins CR, Zareba W, Moss AJ et al. Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction. Arch. Intern. Med. 2004; 164: 440-6.
10. Heinrich J, Schulte H, Schonfeld R, Kohler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb. Haemost. 1995; 73: 374-9.
11. Yang PY, Rui YC. Intercellular adhesion molecule-1 and vascular endothelial growth factor expression kinetics in macrophage-derived foam cells. Life Sci. 2003; 74: 471-80.
12. Lu L, Yang PY, Rui YC et al. Comparative proteome analysis of rat brain and coronary microvascular endothelial cells. Physiol. Res. 2007 (in press).
13. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods 2001; 25: 402-8.
14. Giddings JC. Soluble adhesion molecules in inflammatory and vascular diseases. Biochem. Soc. Trans. 2005; 33: 406-8.
15. Cybulsky MI, Iiyama K, Li H et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 2001; 107: 1255-62.
16. Fiotti N, Altamura N, Fisicaro M et al. MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2006; 26: 1330-6.
17. Trabetti E, Biscuola M, Cavallari U et al. On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease. Eur. J. Hum. Genet. 2006; 14: 127-30.
18. Ramos MA, Kuzuya M, Esaki T et al. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 1998; 18: 1188-96.
19. Qiu Y, Rui YC, Li TJ, Zhang L, Yao PY. Inhibitory effect of extracts of Ginkgo biloba leaves on VEGF-induced hyperpermeability of bovine coronary endothelial cells in vitro. Acta Pharmacol. Sin. 2004; 25: 1306-11.
20. Verma S, Szmitko PE. The vascular biology of peroxisome proliferator-activated receptors: Modulation of atherosclerosis. Can. J. Cardiol. 2006; 22: B12-17.
21. Miyazaki A, Sakai M, Sakamoto Y, Horiuchi S. Acyl-coenzyme A: Cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis. Curr. Opin. Invest. Drugs 2003; 4: 1095-9.
22. Ahmed W, Orasanu G, Nehra V et al. High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: A candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion. Circ. Res. 2006; 98: 490-8.
23. Jacobi J, Kristal B, Chezar J, Shaul SM, Sela S. Exogenous superoxide mediates pro-oxidative, proinflammatory, and procoagulatory changes in primary endothelial cell cultures. Free Radic. Biol. Med. 2005; 39: 1238-48.
24. Kario K, Matsuo T, Kobayashi H. Which factors affect high Ddimer levels in the elderly? Thromb. Res. 1991; 62: 501-8.
25. Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with early atherosclerosis. The ARIC study. Circulation 1995; 91: 284-90.
26. Lee AJ, Fowkes GR, Lowe GD, Rumley A. Determinants of fibrin D-dimer in the Edinburgh Artery Study. Arterioscler. Thromb. Vasc. Biol. 1995; 15: 1094-7.
27. Lassila R, Peltonen S, Lepantalo M, Saarinen O, Kauhanen P, Manninen V. Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. Arterioscler. Thromb. 1993; 13: 1738-42.
28. Herren T, Stricker H, Haeberli A, Do DD, Straub PW. Fibrin formation and degradation in patients with arteriosclerotic disease. Circulation 1994; 90: 2679-86.
29. van der Bom JG, Bots ML, Haverkate F et al. Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease. Thromb. Haemost. 2001; 85: 234-9.
30. Smith FB, Rumley A, Lee AJ, Leng GC, Fowkes FG, Lowe GD. Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants. Br. J. Haematol. 1998; 100: 758-63.
31. Lee AJ, Fowkes FG, Lowe GD, Rumley A. Fibrin D-dimer, haemostatic factors and peripheral arterial disease. Thromb. Haemost. 1995; 74: 828-32.
32. Tataru MC, Heinrich J, Junker R et al. D-Dimer in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Eur. Heart J. 1999; 20: 1493-502.
33. Komarov A, Panchenko E, Dobrovolsky A et al. D-Dimer and platelet aggregability are related to thrombotic events in patients with peripheral arterial occlusive disease. Eur. Heart J. 2002; 23: 1309-16.
34. Folsom AR, Rosamond WD, Shahar E et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The atherosclerosis risk communities (ARIC) study investigators. Circulation 1999; 100: 736-42.
35. de Maat MP, Bladbjerg EM, Drivsholm T, Borch-Johnsen K, Moller L, Jespersen J. Inflammation, thrombosis and atherosclerosis: Results of the Glostrup study. J. Thromb. Haemost. 2003; 1: 950-7.
36. Reganon E, Vila V, Martinez-Sales V et al. Association between inflammation and hemostatic markers in atherothrombotic stroke. Thromb. Res. 2003; 112: 217-21.
37. McDermott MM, Greenland P, Green D et al. D-Dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation 2003; 107: 3191-8.
38. Narins CR, Zareba W, Moss AJ et al. Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction. Arch. Intern. Med. 2004; 164: 440-6.
39. Kubota K, Abe Y, Inamori M et al. Percutaneous transhepatic gall-bladder stenting for recurrent acute acalculous cholecystitis after failed endoscopic attempt. J. Hepatobil. Pancreat. Surg. 2005; 12: 286-9.